http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-007599-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-566 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2002-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_384c45d5e651a7f79ea59963f681c021 |
| publicationDate | 2006-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-007599-B1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITIONS CONTAINING ONE OR SEVERAL STEROIDS, ONE OR SEVERAL TETRAHYDROPHOLATE COMPONENTS AND VITAMIN B |
| abstract | The invention describes a kit for use in a method of hormonal contraception or hormone replacement therapy in female mammals, which includes at least 10 oral unit doses containing at least 1 μg of one or more steroids selected from the range of estrogens and progestogens; at least 0.1 mg of one or more tetrahydrofolate components selected from the group consisting of (6S) -tetrahydrofolate acid, 5-methyl- (6S) -tetrahydrofolate acid, 5-formyl- (6S) -tetrahydrofolate acid, 10-formyl - (6S) -tetrahydrofolate acid, 5,10-methylene- (6R) -tetrahydrofolate acid, 5,10-methenyl- (6R) -tetrahydrofolate acid, 5-formimino (6S) -tetrahydrofolate acid, pharmaceutically acceptable salts of these tetrafolium acids and glutamyl derivatives of said tetrahydrofolic acids; and at least 0.1 mg of vitamin B. The invention also describes a hormonal contraception method and a hormone replacement therapy method, in which a female mammal is orally administered at least once a day with one or more steroidal unit doses, wherein unit doses additionally contain at least 0.1 mg of one or more of the above tetrahydrofolate components and at least 0.1 mg of vitamin B. |
| priorityDate | 2002-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 169.